# Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer

> **NCT05933733** · — · RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 190 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Salvage treatment (surgery and/or radiation therapy)

## Key facts

- **NCT ID:** NCT05933733
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-04
- **Primary completion:** 2028-07
- **Final completion:** 2033-07
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05933733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05933733, "Oncologic Outcomes and Toxicities of Salvage Treatment in Patients With Locoregionally Recurrent Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05933733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*